XTL Biopharmaceuticals Ltd. (XTLB) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    XTL Biopharmaceuticals Lt...

    NASDAQ: XTLB · Real-Time Price · USD
    1.25
    0.00 (0.29%)
    At close: Sep 05, 2025, 2:22 PM
    1.12
    -10.14%
    After-hours: Sep 05, 2025, 04:00 PM EDT

    XTL Biopharmaceuticals Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 451K n/a n/a n/a
    Cost of Revenue
    		 448K n/a n/a n/a
    Gross Profit
    		 3K n/a n/a n/a
    Operating Income
    		 -2.17M -765K -880K -1.03M
    Interest Income
    		 34K 36.00 36K 8K
    Pretax Income
    		 -1.16M -1.78M -1.35M 435K
    Net Income
    		 -1.03M -1.78K -1.35M 435K
    Selling & General & Admin
    		 2.05M 734K 850K 1M
    Research & Development
    		 98K 31K 30K 30K
    Other Expenses
    		 31K n/a n/a n/a
    Operating Expenses
    		 2.17M 765K 880K 1.03M
    Interest Expense
    		 86K n/a 11K 21K
    Selling & Marketing Expenses
    		 178K n/a n/a n/a
    Cost & Expenses
    		 2.62M 765K 880K 1.03M
    Income Tax Expense
    		 -130K n/a n/a n/a
    Shares Outstanding (Basic)
    		 6.73M 5.45M 5.45M 5.32M
    Shares Outstanding (Diluted)
    		 7.04M 5.45M 5.45M 6.16M
    EPS (Basic)
    		 -0.15 -0.00 -0.25 0.10
    EPS (Diluted)
    		 -0.15 -0.00 -0.25 0.07
    EBITDA
    		 -930K -764K -879K -1.03M
    EBIT
    		 -1.13M -765K -880K -1.03M
    Depreciation & Amortization
    		 199K 1K 1K 1K

    Add to Watchlist